Please login to the form below

Not currently logged in
Email:
Password:

dimethyl glutamate

This page shows the latest dimethyl glutamate news and features for those working in and with pharma, biotech and healthcare.

Merck gets CHMP backing for long-delayed oral MS drug

Merck gets CHMP backing for long-delayed oral MS drug

competitive landscape" - with oral therapies such as Novartis' Gilenya (fingolimod) and Biogen's Tecfidera (dimethyl glutamate) reaching or near the market.

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics